Press Releases

Filter between ad hoc announcements and corporate releases
Date	Title
21.08.2025	EvoNext Holdings SA publishes half-year report 2025 AD HOC
25.07.2025	Evolva Holding SA shareholders approve name change to EvoNext Holdings SA
23.07.2025	Evolva Holding SA: Update about earn-out from Danstar AD HOC
03.07.2025	Evolva Holding SA invites to an Extraordinary General Meeting 2025 to change name to EvoNext Holdings SA AD HOC
04.06.2025	Evolva Holding SA Takes Note of GZO Shareholder Communities’ Announcementv AD HOC
27.05.2025	Evolva Holding SA announces offer to acquire GZO AG and launch a regional healthcare platform AD HOC
27.03.2025	Evolva Holding SA shareholders elect Clearway representatives to the Board of Directors AD HOC
06.03.2025	Evolva Holding SA publishes agenda for Annual General Meeting 2025 AD HOC
21.02.2025	Evolva Holding SA publishes IFRS annual report 2024 AD HOC
04.02.2025	Evolva Holding SA: Shareholder Clearway requests general meeting AD HOC
04.02.2025	Evolva Holding SA: Shareholder Clearway requests general meeting AD HOC
30.12.2024	Change in Evolva Holding SA's shareholder structure AD HOC
30.12.2024	Change in Evolva Holding SA's shareholder structure AD HOC
29.10.2024	Evolva Holding AG publishes half-year report 2024 and IFRS annual report 2023 AD HOC
15.07.2024	Evolva Holding SA: Approval of temporary exemption from certain conditions for maintaining listing pursuant to art. 7 Listing Rules; IFRS financial statements for 2023 and half-year 2024 to be publish AD HOC
12.04.2024	Shareholders of Evolva Holding SA in liquidation approve BoD proposals at AGM; revocation of liquidation and delisting also approved whereas introduction of opting-out was rejected AD HOC
25.03.2024	Approval of temporary exemption from certain conditions for maintaining listing pursuant to art. 7 Listing Rules AD HOC
22.03.2024	Evolva Holding in liquidation SA publishes liquidation interim financial statements and agenda for 2024 annual general meeting; reports positive purchase price adjustment of CHF 1,929,000 under SPA
07.03.2024	Shareholder Nice & Green SA requests 3 agenda items to be included in the agenda of the upcoming Annual General Meeting; shareholder Pegasus Global Opportunity Fund Ltd crosses 10% threshold AD HOC
28.12.2023	Evolva and Lallemand close the sale of Evolva AG to Danstar Ferment AG on 28 December 2023
21.12.2023	Shareholders approve the sale of Evolva AG to Lallemand Inc. Swiss subsidiary at extraordinary general meeting
30.11.2023	Evolva convenes extraordinary general meeting (EGM) for 21 December 2023 to approve the sale of Evolva AG to Lallemand Inc. AD HOC
21.11.2023	Evolva enters into an agreement to sell its operations to Lallemand, securing the best possible outcome for the company and its stakeholders AD HOC
14.11.2023	Evolva and Breko broaden partnership by signing agreement for the exclusive distribution of Veri-teTM Resveratrol in Germany, Austria, Thailand and Vietnam
28.09.2023	Evolva and LEHVOSS sign agreement for distribution of Veri-teTM Resveratrol in over a dozen European countries AD HOC
13.09.2023	Evolva and Nice & Green agree on improvements to financing agreement AD HOC
06.09.2023	Evolva receives approval for Veri-teTM Resveratrol in Thailand
24.08.2023	Evolva shareholders approve increase of the conditional capital and upper limit of capital band at extraordinary general meeting of 24 August 2023
24.08.2023	Evolva with good business momentum and significant progress in profitability in 1H 2023, despite major financing challenges AD HOC
28.07.2023	Evolva Holding SA: Evolva convenes extraordinary general meeting (EGM) for 24 August 2023 to secure financing until end of the year AD HOC
25.07.2023	Evolva receives approval for Veri-teTM Resveratrol in Taiwan
26.06.2023	Evolva Holding SA: Evolva signs agreement with Nice & Green to secure financing at least until the end of 2023, continues to pursue strategic alternatives AD HOC
14.06.2023	Evolva informs about renegotiation of financing arrangement, initiates review of strategic alternatives and revokes guidance AD HOC
05.05.2023	Evolva signs multi-year agreement with leading CMO partner to enable supply of Vanillin to global F&F customer of around CHF 35 million until 2026 AD HOC
24.04.2023	Evolva publishes timeline of the Reverse Stock Split
18.04.2023	Evolva shareholders approve all motions proposed by the Board at today’s Annual General Meeting
28.03.2023	Evolva goes Responsible Care at in-cosmetics 2023
24.03.2023	Evolva publishes agenda for 2023 Annual General Meeting AD HOC
24.03.2023	Evolva publishes agenda for 2023 Annual General Meeting AD HOC
09.03.2023	Evolva delivers accelerated revenue growth of 57% in 2022 and substantially improved profitability profile AD HOC
09.03.2023	Evolva delivers accelerated revenue growth of 57% in 2022 and substantially improved profitability profile AD HOC
06.03.2023	Evolva partners with Grace Breeding to replace chemical fertilizers with nature-based alternative AD HOC
06.03.2023	Evolva partners with Grace Breeding to replace chemical fertilizers with nature-based alternative AD HOC
11.01.2023	Evolva delivers strong results with 57% revenue growth and increasing margins AD HOC
11.01.2023	Evolva delivers strong results with 57% revenue growth and increasing margins AD HOC